Literature DB >> 32570566

SPHN - The BioMedIT Network: A Secure IT Platform for Research with Sensitive Human Data.

Diana Coman Schmid1,2, Katrin Crameri2, Sabine Oesterle2, Bernd Rinn1,2, Thierry Sengstag3,2, Heinz Stockinger2.   

Abstract

The BioMedIT project is funded by the Swiss government as an integral part of the Swiss Personalized Health Network (SPHN), aiming to provide researchers with access to a secure, powerful and versatile IT infrastructure for doing data-driven research on sensitive biomedical data while ensuring data privacy protection. The BioMedIT network gives researchers the ability to securely transfer, store, manage and process sensitive research data. The underlying BioMedIT nodes provide compute and storage capacity that can be used locally or through a federated environment. The network operates under a common Information Security Policy using state-of-the-art security techniques. It utilizes cloud computing, virtualization, compute accelerators (GPUs), big data storage as well as federation technologies to lower computational boundaries for researchers and to guarantee that sensitive data can be processed in a secure and lawful way. Building on existing expertise and research infrastructure at the partnering Swiss institutions, the BioMedIT network establishes a competitive Swiss private-cloud - a secure national infrastructure resource that can be used by researchers of Swiss universities, hospitals and other research institutions.

Entities:  

Keywords:  Personalized health; SPHN; confidential data; data privacy; data security; federated computation; health-related data; interoperability; private-cloud; research infrastructure; scientific IT services; sensitive data; service virtualization

Year:  2020        PMID: 32570566     DOI: 10.3233/SHTI200348

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  4 in total

1.  Cohort-based association study of germline genetic variants with acute and chronic health complications of childhood cancer and its treatment: Genetic Risks for Childhood Cancer Complications Switzerland (GECCOS) study protocol.

Authors:  Nicolas Waespe; Sven Strebel; Tiago Nava; Chakradhara Rao S Uppugunduri; Denis Marino; Veneranda Mattiello; Maria Otth; Fabienne Gumy-Pause; André O Von Bueren; Frederic Baleydier; Luzius Mader; Adrian Spoerri; Claudia E Kuehni; Marc Ansari
Journal:  BMJ Open       Date:  2022-01-24       Impact factor: 2.692

2.  Pharmacogenetic Analysis of Voriconazole Treatment in Children.

Authors:  Romy Tilen; Paolo Paioni; Aljoscha N Goetschi; Roland Goers; Isabell Seibert; Daniel Müller; Julia A Bielicki; Christoph Berger; Stefanie D Krämer; Henriette E Meyer Zu Schwabedissen
Journal:  Pharmaceutics       Date:  2022-06-17       Impact factor: 6.525

3.  Towards a national strategy for digital pathology in Switzerland.

Authors:  Andrew Janowczyk; Daniel Baumhoer; Stefan Dirnhofer; Rainer Grobholz; Anja Kipar; Laurence de Leval; Doron Merkler; Olivier Michielin; Holger Moch; Aurel Perren; Sven Rottenberg; Laura Rubbia-Brandt; Mark A Rubin; Christine Sempoux; Markus Tolnay; Inti Zlobec; Viktor Hendrik Koelzer
Journal:  Virchows Arch       Date:  2022-05-27       Impact factor: 4.535

4.  SwissPKcdw - A clinical data warehouse for the optimization of pediatric dosing regimens.

Authors:  Roland Goers; Diana Coman Schmid; Vera F Jäggi; Paolo Paioni; Michal J Okoniewski; Althea Parker; Beat Bangerter; Sofia Georgakopoulou; Thierry Sengstag; Julia Bielicki; Romy Tilen; Swen Vermeul; Stefanie D Krämer; Christoph Berger; Bernd Rinn; Henriette E Meyer Zu Schwabedissen
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-11-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.